Will RPM market keep growing?

This blog post has been written by the person who has mapped the Remote Patient Monitoring market in a clean and beautiful presentation

The Remote Patient Monitoring market has emerged as one of healthcare technology's most promising investment opportunities.

Fueled by aging populations, chronic disease prevalence, and value-based care adoption, the sector continues its remarkable expansion trajectory. Understanding the precise growth dynamics, market penetration rates, and emerging risks becomes crucial for anyone considering entry into this rapidly evolving space.

And if you need to understand this market in 30 minutes with the latest information, you can download our quick market pitch.

What was the actual RPM market growth rate in 2024?

The global Remote Patient Monitoring market achieved a solid 13.7% year-over-year growth rate in 2024, expanding from USD 24.39 billion in 2023 to USD 27.72 billion.

This growth rate reflects the market's transition from pandemic-driven emergency adoption to sustainable, value-based implementation. Unlike the explosive but unsustainable growth seen during COVID-19's peak, 2024's expansion demonstrates genuine market maturation driven by proven clinical outcomes and improved reimbursement frameworks.

The 13.7% figure represents a normalization from earlier volatility while maintaining robust momentum. Healthcare systems increasingly view RPM as essential infrastructure rather than experimental technology, leading to more predictable adoption patterns. Major health insurers expanded coverage for RPM services throughout 2024, providing the financial foundation for sustained growth.

Regional variations showed North America leading with approximately 15% growth, while Europe achieved 12% expansion despite regulatory complexities. Asia Pacific markets demonstrated the highest growth rates at 18-20%, though from smaller baseline numbers.

This growth rate positions RPM favorably compared to other healthcare technology sectors, which averaged 8-10% growth in 2024.

How is the RPM market performing in 2025?

The RPM market is experiencing accelerated growth in 2025, with year-to-date revenue reaching USD 9.4 billion compared to USD 7.2 billion in the same period of 2024—representing a remarkable 30.6% increase.

This acceleration stems from several converging factors. Value-based care contracts have moved beyond pilot phases into full-scale implementation, creating predictable revenue streams for RPM providers. Hospital-at-home programs expanded significantly, with major health systems launching comprehensive remote monitoring initiatives.

AI-enhanced platforms have matured sufficiently to demonstrate measurable improvements in patient outcomes and cost reduction. These platforms now process over 50 million data points daily across major RPM networks, enabling predictive interventions that prevent expensive emergency room visits.

Reimbursement clarity has improved substantially, with Medicare Advantage plans covering RPM services for an additional 12 million beneficiaries in 2025. Private insurers followed suit, expanding coverage to include preventive monitoring for high-risk populations.

The market expansion extends beyond traditional chronic disease management into post-surgical monitoring, mental health tracking, and medication adherence programs, broadening the addressable patient population significantly.

If you want updated data about this market, you can download our latest market pitch deck here

What are the most credible forecasts for RPM growth in 2026?

Leading market research firms project the RPM market will reach between USD 38 billion and USD 85 billion by 2026, with the variation reflecting different methodological approaches and market scope definitions.

What are the expected growth trends over the next 5-10 years?

Independent analysts project sustained high growth rates of 16-19% CAGR over the next five years (2025-2030), with the market reaching USD 56-60 billion by 2030.

The five-year outlook relies on several key assumptions: continued aging of global populations, with the 65+ demographic expanding by 3.2% annually; accelerated AI and machine learning adoption in healthcare settings; and expansion of value-based care contracts covering an additional 40 million patients by 2030.

Ten-year projections (2025-2035) suggest even more aggressive growth at 20-25% CAGR, potentially surpassing USD 80 billion by 2035. This longer-term forecast assumes successful integration of RPM into standard care protocols, widespread adoption of "hospital-at-home" models, and technological breakthroughs in sensor technology and data analytics.

Regional growth patterns will likely diverge significantly. North America and Europe may see moderation to 12-15% CAGR as markets mature, while Asia Pacific, Latin America, and Africa could maintain 25-30% growth rates due to healthcare infrastructure development and government digitization initiatives.

The sustainability of these growth rates depends heavily on resolving current challenges around data interoperability, regulatory harmonization, and demonstrating clear return on investment for healthcare payers beyond pilot programs.

Which factors are driving current and future RPM growth?

Five primary demand drivers fuel the RPM market's expansion trajectory, each representing measurable market forces with quantifiable impact.

• Chronic Disease Management Demand: With 6 in 10 Americans living with chronic conditions requiring continuous monitoring, RPM provides cost-effective alternatives to frequent clinic visits. Cardiovascular disease patients using RPM show 23% reduction in hospital readmissions within 30 days.
• Aging Population Demographics: The global 65+ population grows by 3.2% annually, reaching 95 million Americans by 2030. This demographic requires 40% more healthcare services, creating natural demand for at-home monitoring solutions.
• Value-Based Care Model Adoption: Healthcare systems transitioning from fee-for-service to outcome-based payments find RPM essential for managing patient populations efficiently. Medicare Shared Savings Programs now include RPM metrics in quality assessments.
• Technological Innovation Integration: IoT wearables, AI-driven analytics, and smartphone-enabled platforms have matured sufficiently to provide clinical-grade data. Apple Watch and similar devices now offer FDA-approved monitoring capabilities for atrial fibrillation and blood oxygen levels.
• Expanded Reimbursement Frameworks: Medicare expanded CPT codes for RPM services to include acute conditions, while Medicare Advantage plans cover RPM for an additional 12 million beneficiaries in 2025. European national health services are implementing similar coverage expansions.

Need a clear, elegant overview of a market? Browse our structured slide decks for a quick, visual deep dive.

What are the biggest obstacles that could slow RPM growth?

Four significant risks threaten to decelerate RPM market expansion, each representing structural challenges requiring strategic solutions.

Reimbursement uncertainty remains the primary growth obstacle. While coverage has expanded, variability in payer policies and evolving regulatory frameworks create investment hesitancy among healthcare providers. Medicare reimbursement rates for RPM services vary by 40% across different geographic regions, making business case development challenging.

Data interoperability and integration challenges fragment the market's efficiency potential. Most healthcare systems operate with legacy EHR systems that lack standardized protocols for RPM data integration. This fragmentation forces providers to maintain separate monitoring platforms, increasing operational complexity and costs.

Digital literacy and infrastructure gaps limit market penetration, particularly in rural and low-income populations. Approximately 30% of Medicare beneficiaries lack reliable broadband access required for continuous monitoring, while patient familiarity with digital health tools varies significantly across demographic groups.

Alert fatigue and data deluge risks threaten clinical value proposition. Healthcare providers report receiving 40-60% non-actionable alerts from RPM systems, leading to clinician burnout and reduced responsiveness to genuine emergencies. This challenge requires sophisticated AI filtering and clinical workflow integration to resolve.

Regulatory fragmentation across international markets creates scalability challenges for RPM technology companies seeking global expansion, particularly in data privacy compliance and device approval processes.

If you want clear information about this market, you can download our latest market pitch deck here

How saturated is the current RPM market and what room exists for new entrants?

The RPM market shows moderate saturation in developed regions but significant opportunity in emerging markets and specialized applications.

Current penetration data indicates approximately 30 million U.S. patients actively use RPM services as of 2024, representing roughly 15% of the eligible chronic disease population. Patient satisfaction rates reach 80%, suggesting strong retention potential but also indicating room for quality improvements and service expansion.

Geographic saturation varies dramatically. North American and European markets show 25-30% penetration in urban areas but less than 10% in rural regions. Asia Pacific, Latin America, and African markets demonstrate single-digit penetration rates, creating substantial growth opportunities for new entrants with cost-effective solutions.

Vertical specialization offers entry points for new companies. While chronic disease monitoring dominates current applications, emerging opportunities exist in post-surgical recovery monitoring, mental health tracking, medication adherence programs, and pediatric monitoring. These specialized segments remain largely underserved by established players.

Technology differentiation provides competitive advantages for new entrants. Companies developing edge computing solutions, advanced biomarker monitoring, or integrated telehealth platforms can capture market share despite incumbent presence. The market rewards innovation in user experience, clinical workflow integration, and cost reduction.

Looking for the latest market trends? We break them down in sharp, digestible presentations you can skim or share.

Which customer segments show the strongest RPM adoption?

Three customer segments demonstrate exceptional RPM adoption rates, each driven by specific clinical and economic factors.

How is regulatory policy evolving and what impact will this have on RPM growth?

Regulatory evolution across major markets shows accelerating support for RPM implementation, though with significant regional variations that create both opportunities and challenges.

North American regulatory development leads global trends. The Centers for Medicare & Medicaid Services (CMS) expanded RPM CPT codes to include acute conditions beyond chronic disease management, while pilot "Hospital-At-Home" programs received permanent approval for eligible conditions. Rural broadband initiatives allocated $42 billion in infrastructure funding, directly supporting RPM accessibility in underserved areas.

European regulatory frameworks are converging toward RPM support through national telehealth reimbursement schemes. The UK's NHS implemented comprehensive RPM coverage for cardiovascular and diabetes monitoring, while Germany's Digital Healthcare Act (DVG) enables prescription of digital therapeutics including RPM applications. Scandinavian countries lead with integrated social care and healthcare RPM programs.

Asia Pacific markets show government-led RPM adoption initiatives. India's Production Linked Incentive (PLI) scheme provides subsidies for domestic wearable device manufacturing, while China's 14th Five-Year Plan allocates substantial funding for digital health infrastructure. Japan's aging society initiatives include comprehensive RPM integration into national healthcare delivery.

The regulatory impact on growth will be substantial but varied. Improved reimbursement clarity accelerates provider adoption and creates predictable revenue models for RPM companies. However, inconsistent international regulations pose challenges for global scalability, requiring customized compliance approaches for different markets.

Data privacy regulations, particularly GDPR in Europe and expanding state-level privacy laws in the US, create additional compliance costs but also competitive advantages for companies with robust data protection capabilities.

If you want fresh and clear data on this market, you can download our latest market pitch deck here

What technological advances will unlock additional RPM growth?

Four technological breakthrough areas will drive the next wave of RPM market expansion, each addressing current limitations while creating new application possibilities.

Artificial Intelligence and predictive analytics represent the most immediate growth catalyst. Advanced algorithms now process multivariate patient data to predict health events 3-7 days before clinical symptoms appear. These systems reduce false alerts by 60% while identifying 85% of genuine emergencies, directly addressing the alert fatigue problem that limits current RPM effectiveness.

Edge computing combined with 5G networks enables real-time data transmission with sub-100ms latency, crucial for acute monitoring applications. This technology supports continuous cardiac monitoring, real-time medication adherence tracking, and emergency response systems that require immediate data processing and clinical intervention capabilities.

Integrated digital platforms that unify RPM data with telehealth consultations and electronic health records create comprehensive patient management ecosystems. These platforms reduce provider workflow complexity and enable seamless care coordination across multiple specialties and care settings.

Advanced biomarker monitoring through multimodal sensors expands RPM beyond traditional vital signs. New sensor technologies capture acoustic biomarkers for respiratory conditions, gait analysis for neurological monitoring, and wound healing assessment through computer vision, broadening the addressable patient population significantly.

Planning your next move in this new space? Start with a clean visual breakdown of market size, models, and momentum.

Which companies and regions are leading RPM market growth?

Market leadership concentration varies significantly by region, with established healthcare technology companies dominating North America while emerging players gain traction in developing markets.

Is current RPM growth sustainable or driven by temporary factors?

Current RPM growth demonstrates structural sustainability indicators alongside some transitional elements that require careful evaluation for long-term investment decisions.

Sustainable growth factors include demographic trends that will persist for decades. The global aging population represents an irreversible shift creating permanent demand for at-home monitoring solutions. Chronic disease prevalence continues rising across all developed and developing economies, independent of economic cycles or technological trends.

Value-based care adoption has moved beyond experimental phases into permanent healthcare delivery transformation. Medicare Shared Savings Programs and Medicare Advantage risk-based contracts now incorporate RPM metrics as standard quality measures, creating institutional momentum that persists regardless of political changes.

However, some growth elements reflect temporary accelerants. Pandemic-driven telehealth adoption created artificial demand spikes that are normalizing to more sustainable levels. Government emergency funding for digital health infrastructure will eventually conclude, potentially slowing expansion in rural and underserved markets.

The transition from RPM 1.0 (volume-based device sales and basic monitoring) to RPM 2.0 (outcome-driven service models with integrated care delivery) will determine long-term sustainability. Companies demonstrating measurable clinical impact and cost reduction will capture sustainable market share, while those relying primarily on device sales may face margin compression.

Evidence suggests the market is successfully making this transition, with 70% of new RPM contracts in 2025 including outcome-based payment components compared to 20% in 2022.

Wondering who's shaping this fast-moving industry? Our slides map out the top players and challengers in seconds.

Conclusion

Sources

1. MarketsandMarkets - Remote Patient Monitoring Market
2. Roots Analysis - Telemedicine Tools Market
3. Research and Markets - RPM Market Forecasts
4. MarketsandMarkets - RPM Press Release
5. LinkedIn - RPM System Market Drivers
6. Grand View Research - RPM Devices Market
7. LinkedIn - RPM Industry CAGR Analysis
8. Market.us - RPM Statistics
9. Signify Research - RPM Market 2026
10. Globe Newswire - RPM Market 2032 Forecast
11. Intuition Labs - RPM US 2025 Landscape
12. Precedence Research - Remote Health Monitoring
13. MediTech Insights - RPM Market
14. Precedence Research - RPM Systems Market
15. HealthSnap - Top RPM Companies 2024